Pharmaceutical Business Review
Anonymous User | Login

Daiichi Sankyo Subsidiary Submits NDA For SUN Y7017 In Japan

Published: 08-Feb-2010

Daiichi Sankyo has announced that its subsidiary, Asubio Pharma, has submitted a New Drug Application in Japan for the manufacturing and marketing of SUN Y7017 (generic name: Memantine hydrocholoride). It was developed for the treatment of alzheimer’s type dementia (AD).

SUN Y7017 is an N-methyl-D-aspartate (NMDA) receptor antagonist developed by Merz Pharmaceuticals. This drug was approved for use in the treatment of AD by the EMEA in 2002, and by the US Food and Drug Administration in 2003. As of January 2010, this drug is marketed in more than 60 countries around the world.

Daiichi Sankyo said that Memantine is the first in class of medications, which acts on the glutamatergic system by blocking NMDA glutamate receptors. Memantine is marketed under the brands - Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck, and Memox by Unipharm.

Share

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

World Courier

Offering Fully-Integrated GxP-Compliant Global Transport and Storage for the Pharmaceutical Industry...

Vetter Pharma International

High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...

TOPRA

Healthcare Regulatory Affairs ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

Tarius

Your One Source for Global Regulatory Information ...

Swiss BioAnalytics

Quantitative and Qualitative LC/MS Services for Preclinical and Clinical Trials ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

CaseBase Management

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

SafetyBase Interchange

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

ClinicalBase Trial

BaseCon was established in 1999 to support the pharmaceutical sector with innovative IT so ...

Reliable Prediction of White Plasma Levels

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Kinetics and Metabolism

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Drug Safety Evaluation

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (Takeda) is a global pharmaceutical company mainl ...

Astellas Pharma Inc.

Astellas Pharma Inc. (Astellas) is a global pharmaceutical company engaged in developin ...

Kyowa Hakko Kirin Co., Ltd.

Kyowa Hakko Kirin Co., Ltd.(Kyowa Hakoo), formely known as KYOWA HAKKO KOGYO Co., Ltd., ...

Shionogi & Co., Ltd.

Shionogi & Co., Ltd., (Shionogi) is principally engaged in the manufacture of pharmaceu ...

CardioVascular BioTherapeutics, Inc.

Cardiovascular Biotherapeutics, Inc. (CVBT) is a biopharmaceutical company. It is engag ...

Suppliers Product News

World Courier CTSCS Depots Provide Dedicated Storage for GMO Products

In response to growing client demand and based on recently-established international biosafety regulations, World Courier has begun rolling out dedicated storage areas for GMO-derived pharmaceutical products throughout its global investigational drug storage network.

World Courier Triples Clinical Trial Storage Capacity Worldwide with Two New Facilities and Client-Driven Expansion

World Courier expands its GMP-compliant Clinical Trial Supply Chain Services (CTSCS) network, facilitating access to growing pharmaceutical markets in Africa and Australia.

World Courier Achieves Coveted GxP-Compliant Status Worldwide with Focus on GDP, Quality Management

With a fully GxP-compliant transport and supply chain system in place, World Courier meets the most demanding industry requirements for managing time- and temperature-sensitive clinical trial materials used in global studies.

Vetter Dedicates New Facility in Suburban Chicago

The new facility will enable collaboration very early in development process

Pharma Supplier Vetter Shares Pride in Consistent Growth and International Success with Distinguished Visitor Minister zu Guttenberg

Economics and Technology Minister visits global leader's headquarters in southern Germany.

Vetter Packages Success with New Facility

Vetter's new secondary packaging operation allows the company to double its production in half the time.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address